FDA Technical Corrections Bill Could Address Trial Registry Requirements
This article was originally published in The Gray Sheet
Executive Summary
Clinical trial registry requirements contained in the recently enacted FDA Amendments Act are likely to be clarified in a "technical corrections" bill in the coming weeks, device industry lobbyists say